Physical therapy continues to be a growing field with a positive outlook as a career path. It is a $30 billion industry with a projected 30% job growth over the next 10 years. This expansion is due to an increase in sedentary lifestyles, an aging population, steady growth in employment and early specialization in sports.
Steady in revenue growth since 2007, this market is projected to reach $45.7 billion by 2023 if it continues to follow the average annual pace of 6.2% The physical therapy market is expected to continue to flourish, but there will be new innovations and technology in physical therapy that may disrupt the industry as we know it.
Frequency Therapeutics, Inc. (NASDAQ: FREQ), a clinical-stage biotechnology company, focuses on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company’s lead product candidate is FX-322, which is in phase 2a clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322. Frequency Therapeutics, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Electromedical Technologies, Inc. (OTC: EMED) is a bioelectronics manufacturing company and its mission is to improve global wellness for people suffering from various painful conditions by relieving chronic and acute pain using energy, frequency and vibration as an alternative to pharmaceuticals; and one day, read and modify electrical signals passing along nerves in the body, to restore long-term health. We believe that we do this by delivering innovative solutions providing fast and long lasting pain relief across the broadest range of ailments. We engineer simple-to-use bioelectronics therapy devices, which send a proprietary sequence of electrical signals. We believe our devices have proven to be highly effective over the past decade and have the technological capability to be used in medical research.